LENSAR Secures $87M in Financing to Support Market Expansion of Its Laser Cataract Surgery System
October 02, 2013 at 08:04 AM EDT
LENSAR Inc., developer of the next-generation LENSAR™ Laser System for refractive laser-assisted cataract surgery (ReLACS), today announced the closing of $27 million in private equity financing and up to $60 million in debt financing. New investor PDL BioPharma (NASDAQ: PDLI ) is providing the credit agreement while Aisling Capital,
